Irritable Bowel Syndrome Trial, Recruiting NCT05293769 Sponsor: Universitair Ziekenhuis Brussel Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT05293769
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 65 years old
  • People who are willing and able to sign a written consent form
  • People who are currently living in Belgium

Who may not be able to join:

  • People who have followed a diet in the 8 weeks before joining the trial
  • People who have a known or suspected eating disorder
  • People who have a major psychiatric (mental health) condition
  • People who have a known gut or digestive disease (note: irritable bowel syndrome is allowed)
  • People who have had any form of cancer in the past 3 years (note: a specific type of minor skin cancer called basocellular carcinoma is allowed)
  • People who have received chemotherapy in the past 6 months
  • People who have had a stomach or gut infection in the past 6 months, meaning an illness lasting 2 or more days in a row with symptoms such as fever, vomiting, sudden diarrhoea, or hospitalisation (confirm with trial site)
  • People who have had previous abdominal (stomach area) surgery, except for appendix removal or gallbladder removal, which are allowed
  • People who drink more than 14 units of alcohol per week
  • People who use illegal drugs
  • People who take medications known to have significant effects on the digestive system (confirm with trial site)
  • People who have recently started taking nerve-affecting medications (sometimes called neuromodulators) less than 3 months before joining — these medications are allowed if the dose has been stable for at least 3 months
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +32 2 477

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universitair Ziekenhuis Brussel
Registry
ClinicalTrials.gov
Start date
15 October 2022
Est. completion
31 December 2030

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

To validate the newly developed food frequency questionnaire against the standard 4-day food diary across different populations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov